Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercetagetin is a naturally occurring flavonoid, specifically a hexahydroxyflavone, derived from plants such as *Flos eriocauli* (the flower of *Eriocaulon buergerianum*). It is traditionally used in Chinese medicine for its anti-inflammatory and analgesic properties. Research indicates it has potential therapeutic applications in rheumatoid arthritis by alleviating inflammatory osteoclastogenesis. Its mechanism involves the activation of the Nrf2 signaling pathway and the modulation of the Pten/AKT/Nfatc1 axis. Additionally, quercetagetin is recognized as a potent, ATP-competitive inhibitor of PIM1 kinase, suggesting potential utility in oncology and other inflammatory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quercetagetin.